{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreierndvic7mywnphnw4qywhu7nvy62nqnvyzjjpe54sxntwparut4a",
    "uri": "at://did:plc:svcthvzunxmjidtlw23zva6n/app.bsky.feed.post/3mgx66ruslnv2"
  },
  "path": "/2026/03/13/insilico-medicine-to-announce-2025-financial-results-on-march-30-2026/",
  "publishedAt": "2026-03-13T13:59:00.000Z",
  "site": "https://laotiantimes.com",
  "tags": [
    "Cision PR Newswire"
  ],
  "textContent": "CAMBRIDGE, Mass., March 13, 2026 /PRNewswire/ — Insilico Medicine (HKEX: 3696.HK, “Insilico” or the “Company”), a clinical-stage biotechnology company powered by generative artificial intelligence for drug discovery and development, today announced that it will report its financial results for the year ended December 31, 2025, and provide a business update on March 30, 2026. The […]",
  "title": "Insilico Medicine to Announce 2025 Financial Results on March 30, 2026"
}